Literature DB >> 9708198

Latest tests for prostatic neoplasia.

W J Marshall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9708198      PMCID： PMC500691          DOI： 10.1136/jcp.51.5.347

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  28 in total

1.  AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND.

Authors:  A B Gutman; E B Gutman
Journal:  J Clin Invest       Date:  1938-07       Impact factor: 14.808

2.  Free PSA as a percentage of the total: where do we go from here?

Authors:  R A Moore
Journal:  Clin Chem       Date:  1997-09       Impact factor: 8.327

Review 3.  Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales.

Authors:  J Chamberlain; J Melia; S Moss; J Brown
Journal:  Br J Urol       Date:  1997-05

4.  A prostate antigen in sera of prostatic cancer patients.

Authors:  L D Papsidero; M C Wang; L A Valenzuela; G P Murphy; T M Chu
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

5.  The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia.

Authors:  C Stephan; M Lein; K Jung; D Schnorr; S A Loening
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

6.  A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.

Authors:  U H Stenman; J Leinonen; H Alfthan; S Rannikko; K Tuhkanen; O Alfthan
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

7.  Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.

Authors:  J E Oesterling; S J Jacobsen; G G Klee; K Pettersson; T Piironen; P A Abrahamsson; U H Stenman; B Dowell; T Lövgren; H Lilja
Journal:  J Urol       Date:  1995-09       Impact factor: 7.450

8.  Screening for prostatic carcinoma with prostate specific antigen: results of the second year.

Authors:  M K Brawer; J Beatie; M H Wener; R L Vessella; S D Preston; P H Lange
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

9.  Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.

Authors:  W J Catalona; D S Smith; R L Wolfert; T J Wang; H G Rittenhouse; T L Ratliff; R B Nadler
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

10.  Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers.

Authors:  A F Prestigiacomo; T A Stamey
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.